IREN

IREN Limited

There isn't enough reported data to score IREN yet.

LCID

Lucid Group, Inc.

52
Fundamentals65/ 100
Valuation50/ 100
Upside potential62/ 100
Risk potential38/ 100

LCID lost money over the past year, so it has no meaningful PE right now. Analysts expect losses to shrink, though they disagree widely on how much.

IREN Fundamentals

MetricStatus
Under pressure
Weak
N/A
N/A

IREN's revenue and profitability are currently under pressure. Free cash flow and net leverage aren't meaningful measures for financial services companies like IREN.

LCID Fundamentals

MetricStatus
Healthy
Weak
Weak
Unavailable

LCID's revenue is currently healthy, but its profitability and cash flow are weak. There isn't enough data to rate its balance sheet.

IREN PE Valuation

IREN has no meaningful PE right now: it lost money over the past year.

LCID PE Valuation

LCID has no meaningful PE right now: it lost money over the past year.

IREN Forward outlook

MetricOutlook
--
Losses growing
Strong growth
Strongly improving
Limited
Low

Analysts expect IREN's losses to grow, with revenue growing. However, they disagree widely on these estimates.

LCID Forward outlook

MetricOutlook
--
Losses shrinking
Strong growth
--
Limited
Low

Analysts expect LCID's losses to shrink, with revenue growing. However, they disagree widely on these estimates.

IREN Risk to reward

ScenarioChangePrice
UpsideUnknown—
DownsideUnknown—

Calculated from the latest close: $19.48 on Nov 12.

There is not enough scenario data to compare IREN and LCID's risk to reward.

LCID Risk to reward

ScenarioChangePrice
Upside+63%$5.30
Downside-38%$2.02

Calculated from the latest close: $3.25 on Nov 12.

There is not enough scenario data to compare IREN and LCID's risk to reward.

IREN Earnings Per Share

Q4 2023: $-0.29Q1 2024: $-0.16Q2 2024: $-0.20Q3 2024: $-0.39Q4 2024: $-0.44Q1 2025: $-0.59Q2 2025: $0.25Q3 2025: $1.60Q4 2025: $1.18Q1 2026: $0.51Q2 2026: $-2.22Q3 2026: $-3.96
Q4 2023: $-0.29Q1 2024: $-0.16Q2 2024: $-0.20Q3 2024: $-0.39Q4 2024: $-0.44Q1 2025: $-0.59Q2 2025: $0.25Q3 2025: $1.60Q4 2025: $1.18Q1 2026: $0.51Q2 2026: $-2.22Q3 2026: $-3.96
QuarterTTM EPSYoY
Q3 2026-$3.96-347%
Q2 2026-$2.22-988%
Q1 2026$0.51+$1.10
Q4 2025$1.18+$1.62
Q3 2025$1.60+$1.99
Q2 2025$0.25+$0.45
Q1 2025-$0.59-$0.43
Q4 2024-$0.44-$0.15

IREN has swung to a loss: it lost $3.96 per share over the past year, after a profit the year before.

LCID Earnings Per Share

Q4 2023: $-13.60Q1 2024: $-12.30Q2 2024: $-11.70Q3 2024: $-13.00Q4 2024: $-12.50Q1 2025: $-11.90Q2 2025: $-11.30Q3 2025: $-10.51Q4 2025: $-12.09Q1 2026: $-13.15Q2 2026: $-13.65Q3 2026: $-13.08
Q4 2023: $-13.60Q1 2024: $-12.30Q2 2024: $-11.70Q3 2024: $-13.00Q4 2024: $-12.50Q1 2025: $-11.90Q2 2025: $-11.30Q3 2025: $-10.51Q4 2025: $-12.09Q1 2026: $-13.15Q2 2026: $-13.65Q3 2026: $-13.08
QuarterTTM EPSYoY
Q3 2026-$13.08-$2.57
Q2 2026-$13.65-$2.35
Q1 2026-$13.15-$1.25
Q4 2025-$12.09+$0.41
Q3 2025-$10.51+$2.49
Q2 2025-$11.30+$0.40
Q1 2025-$11.90+$0.40
Q4 2024-$12.50+$1.10

LCID has the edge over IREN on earnings, with more consistent year-over-year improvement.

IREN Quarterly Revenue

Q4 2023: $42MQ1 2024: $54MQ2 2024: $57MQ3 2024: $53MQ4 2024: $116MQ1 2025: $145MQ2 2025: $187MQ3 2025: $240MQ4 2025: $185MQ1 2026: $145MQ2 2026: $137MQ3 2026: $228M
Q4 2023: $42MQ1 2024: $54MQ2 2024: $57MQ3 2024: $53MQ4 2024: $116MQ1 2025: $145MQ2 2025: $187MQ3 2025: $240MQ4 2025: $185MQ1 2026: $145MQ2 2026: $137MQ3 2026: $228M
QuarterRevenueYoY
Q3 2026$228M-5.1%
Q2 2026$137.2M-27%
Q1 2026$144.8M0%
Q4 2025$184.7M+59%
Q3 2025$240.3M+355%
Q2 2025$187.3M+230%
Q1 2025$144.8M+168%
Q4 2024$116.1M+176%

IREN's revenue has held roughly level: $228M last quarter, down 5.1% from the same quarter a year ago.

LCID Quarterly Revenue

Q4 2023: $157MQ1 2024: $173MQ2 2024: $201MQ3 2024: $200MQ4 2024: $234MQ1 2025: $235MQ2 2025: $259MQ3 2025: $337MQ4 2025: $523MQ1 2026: $282MQ2 2026: $405MQ3 2026: $350M
Q4 2023: $157MQ1 2024: $173MQ2 2024: $201MQ3 2024: $200MQ4 2024: $234MQ1 2025: $235MQ2 2025: $259MQ3 2025: $337MQ4 2025: $523MQ1 2026: $282MQ2 2026: $405MQ3 2026: $350M
QuarterRevenueYoY
Q3 2026$350.3M+4.1%
Q2 2026$405.3M+56%
Q1 2026$282.5M+20%
Q4 2025$522.7M+123%
Q3 2025$336.6M+68%
Q2 2025$259.4M+29%
Q1 2025$235M+36%
Q4 2024$234.5M+49%

LCID's revenue has grown year over year for 11 quarters in a row: $350M last quarter, up 4.1% from the same quarter a year ago.

IREN Free Cash Flow

Q4 2023: −$29MQ1 2024: −$222MQ2 2024: −$163MQ3 2024: −$387MQ4 2024: −$134MQ1 2025: −$351MQ2 2025: $16MQ3 2025: −$38MQ4 2025: −$468MQ1 2026: −$874MQ2 2026: $482MQ3 2026: −$1.6B
Q4 2023: −$29MQ1 2024: −$222MQ2 2024: −$163MQ3 2024: −$387MQ4 2024: −$134MQ1 2025: −$351MQ2 2025: $16MQ3 2025: −$38MQ4 2025: −$468MQ1 2026: −$874MQ2 2026: $482MQ3 2026: −$1.6B
QuarterFree cash flowYoY
Q3 2026-$1.6B-$1.6B
Q2 2026$482.2M+2895%
Q1 2026-$873.8M-$523.1M
Q4 2025-$468M-$334M
Q3 2025-$38M+$349.4M
Q2 2025$16.1M+$179M
Q1 2025-$350.7M-$128.7M
Q4 2024-$134M-$105.2M

IREN has the edge over LCID on cash flow, with more consistent year-over-year improvement.

LCID Free Cash Flow

Q4 2023: −$747MQ1 2024: −$715MQ2 2024: −$741MQ3 2024: −$622MQ4 2024: −$825MQ1 2025: −$590MQ2 2025: −$1BQ3 2025: −$955MQ4 2025: −$1.2BQ1 2026: −$1.4BQ2 2026: −$1.5BQ3 2026: −$1B
Q4 2023: −$747MQ1 2024: −$715MQ2 2024: −$741MQ3 2024: −$622MQ4 2024: −$825MQ1 2025: −$590MQ2 2025: −$1BQ3 2025: −$955MQ4 2025: −$1.2BQ1 2026: −$1.4BQ2 2026: −$1.5BQ3 2026: −$1B
QuarterFree cash flowYoY
Q3 2026-$1B-$84.2M
Q2 2026-$1.5B-$463.2M
Q1 2026-$1.4B-$849M
Q4 2025-$1.2B-$417.1M
Q3 2025-$955.5M-$333M
Q2 2025-$1B-$271.6M
Q1 2025-$589.9M+$125.1M
Q4 2024-$824.8M-$77.6M

LCID has burned cash in almost every quarter: −$5.2B over the past year, against −$3.4B the year before.

IREN Total Shares

Q4 2023: 73MQ1 2024: 112MQ2 2024: 186MQ3 2024: 189MQ4 2024: 210MQ1 2025: 219MQ2 2025: 257MQ3 2025: 362MQ4 2025: 298MQ1 2026: 334MQ2 2026: 316MQ3 2026: 399M
Q4 2023: 73MQ1 2024: 112MQ2 2024: 186MQ3 2024: 189MQ4 2024: 210MQ1 2025: 219MQ2 2025: 257MQ3 2025: 362MQ4 2025: 298MQ1 2026: 334MQ2 2026: 316MQ3 2026: 399M
PeriodChange %Net change
Quarterly+26%+82.4M shares
1 year+10%+36.9M shares
3 years+511%+333M shares
5 years+624%+344M shares
Available history+2346%+382M shares

IREN has the edge over LCID on shareholder dilution, with a more favorable share count trend.

LCID Total Shares

Q4 2023: 208MQ1 2024: 230MQ2 2024: 231MQ3 2024: 232MQ4 2024: 245MQ1 2025: 304MQ2 2025: 306MQ3 2025: 312MQ4 2025: 313MQ1 2026: 328MQ2 2026: 382MQ3 2026: 395M
Q4 2023: 208MQ1 2024: 230MQ2 2024: 231MQ3 2024: 232MQ4 2024: 245MQ1 2025: 304MQ2 2025: 306MQ3 2025: 312MQ4 2025: 313MQ1 2026: 328MQ2 2026: 382MQ3 2026: 395M
PeriodChange %Net change
Quarterly+3.3%+12.5M shares
1 year+26%+82.4M shares
3 years+73%+166M shares

LCID has 395M diluted shares, up 26% from a year ago.

IREN Net Leverage

Q4 2023: -11.0xQ1 2024: -10.6xQ2 2024: -15.9xQ3 2024: -16.7xQ4 2024: -4.6xQ1 2025: 3.3xQ2 2025: 2.0xQ3 2025: 4.1xQ4 2025: 22.2xQ1 2026: 157.6x
Q4 2023: -11.0xQ1 2024: -10.6xQ2 2024: -15.9xQ3 2024: -16.7xQ4 2024: -4.6xQ1 2025: 3.3xQ2 2025: 2.0xQ3 2025: 4.1xQ4 2025: 22.2xQ1 2026: 157.6x
QuarterNet LeverageStatus
Q1 2026157.6xHigh
Q4 202522.2xHigh
Q3 20254.1xHigh
Q2 20252.0xModerate
Q1 20253.3xElevated
Q4 2024-4.6xNet Cash
Q3 2024-16.7xNet Cash
Q2 2024-15.9xNet Cash

IREN's net debt is more than 20 years of its operating earnings (EBITDA), up from 3.3 years a year ago. Net leverage isn't a meaningful measure for financial services companies like IREN.

LCID Net Leverage

LCID's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.

IREN Weekly Momentum

MetricValueStatus
RSI33.3Neutral
Stochastic8.2Oversold

IREN's weekly RSI is 33 (neutral) and its Stochastic is 8 (oversold).

LCID Weekly Momentum

MetricValueStatus
RSI32.9Neutral
Stochastic7.1Oversold

LCID's weekly RSI is 33 (neutral) and its Stochastic is 7 (oversold).

IREN PE vs Financial Services Sector

MetricIRENSector medianRelative
PEN/A13x—

IREN has no meaningful PE right now: it lost money over the past year.

LCID PE vs Consumer Cyclical Sector

LCID has no meaningful PE right now: it lost money over the past year.

IREN Weekly Moving Averages

Moving averageMA priceRelative
8 week MA$29.835% below
20 week MA$36.246% below
50 week MA$42.854% below
100 week MA$32.039% below
200 week MA$19.12.1% above

IREN has the edge over LCID on trend strength, trading above more of its moving averages.

LCID Weekly Moving Averages

Moving averageMA priceRelative
8 week MA$3.537.9% below
20 week MA$4.8833% below
50 week MA$7.3356% below
100 week MA$15.479% below
200 week MA$31.990% below

LCID is in a downtrend: it's below all five of its weekly moving averages, and 90% below its 200-week average.

IREN Yearly ROI

YearStart priceEnd priceROI
2021$24.8$17.2-31%
2022$17.2$1.19-93%
2023$1.19$7.15+501%
2024$7.15$10.7+50%
2025$10.7$40.3+276%
2026 YTD$40.3$19.5-52%

IREN has the edge over LCID on returns for 2026, with the stronger performance.

LCID Yearly ROI

YearStart priceEnd priceROI
2020$98.9$100.4+1.5%
2021$100.4$376.4+275%
2022$376.4$67.0-82%
2023$67.0$42.1-37%
2024$42.1$32.0-24%
2025$32.0$11.4-64%
2026 YTD$11.4$3.25-72%

LCID has finished four years in a row lower, and it's down 72% so far in 2026.

Give your agent the market.

Get API key